Abivax nears $11 billion valuation after fundraising eases M&A pressure
By Sabrina ValleAbivax SA EURONEXT:ABVX raised $800 million in an expanded share sale on Wednesday after strong investor demand, valuing the French biotechnology company at nearly $11 billion and easing pressure to pursue a near-term sale.Abivax, which is developing treatments for chronic inflammat…